Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: A prospective randomized trial

Z. A. Saeed, R. A. Cole, Francisco C Ramirez, F. E. Schneider, K. S. Hepps, D. Y. Graham

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background and Study Aims: Rebleeding after initial endoscopic hemostasis remains an important determinant of poor prognosis in patients with ulcer hemorrhage. Prospective identification of patients who are at high risk for rebleeding, and directing further therapeutic measures in these patients, would be expected to improve the prognosis. Patients and Methods: We used our previously described scoring system (the Baylor Bleeding Score) to identify patients at increased risk for rebleeding after initially successful endoscopic hemostasis, and randomized them into retreatment and no-retreatment groups. Patients in the retreatment group received additional endoscopic heat probe therapy at 24 hours, the follow-up was otherwise similar. Forty men with major ulcer hemorrhage were randomized, 19 to the retreatment group and 21 to the no-retreatment group. Patients in the two groups had similar Baylor Bleeding Scores, blood transfusion needs (median three vs. two units), ulcer sites (duodenal 57% vs. 43%), stigmata of hemorrhage (actively bleeding 68% vs. 67%), and received similar initial endoscopic therapy (heat probe 240 J vs. 300 J). Patients in the retreatment group received additional heat probe therapy (median 165 J) at 24 hours. Results: Rebleeding, requiring significantly more blood transfusion, occurred in 24% of the no-retreatment group patients compared to none of the retreatment group patients (p < 0.05). Conclusions: Endoscopic retreatment after successful initial endoscopic hemostasis prevents rebleeding in high-risk patients with ulcer bleeding.

Original languageEnglish (US)
Pages (from-to)288-294
Number of pages7
JournalEndoscopy
Volume28
Issue number3
StatePublished - Mar 1996
Externally publishedYes

Fingerprint

Retreatment
Hemostasis
Ulcer
Hemorrhage
Endoscopic Hemostasis
Hot Temperature
Blood Transfusion
Christianity
Therapeutics
Duodenal Ulcer

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Saeed, Z. A., Cole, R. A., Ramirez, F. C., Schneider, F. E., Hepps, K. S., & Graham, D. Y. (1996). Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: A prospective randomized trial. Endoscopy, 28(3), 288-294.

Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding : A prospective randomized trial. / Saeed, Z. A.; Cole, R. A.; Ramirez, Francisco C; Schneider, F. E.; Hepps, K. S.; Graham, D. Y.

In: Endoscopy, Vol. 28, No. 3, 03.1996, p. 288-294.

Research output: Contribution to journalArticle

Saeed, ZA, Cole, RA, Ramirez, FC, Schneider, FE, Hepps, KS & Graham, DY 1996, 'Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: A prospective randomized trial', Endoscopy, vol. 28, no. 3, pp. 288-294.
Saeed, Z. A. ; Cole, R. A. ; Ramirez, Francisco C ; Schneider, F. E. ; Hepps, K. S. ; Graham, D. Y. / Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding : A prospective randomized trial. In: Endoscopy. 1996 ; Vol. 28, No. 3. pp. 288-294.
@article{948d6de8316b4d738f044071d0aa3d9d,
title = "Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: A prospective randomized trial",
abstract = "Background and Study Aims: Rebleeding after initial endoscopic hemostasis remains an important determinant of poor prognosis in patients with ulcer hemorrhage. Prospective identification of patients who are at high risk for rebleeding, and directing further therapeutic measures in these patients, would be expected to improve the prognosis. Patients and Methods: We used our previously described scoring system (the Baylor Bleeding Score) to identify patients at increased risk for rebleeding after initially successful endoscopic hemostasis, and randomized them into retreatment and no-retreatment groups. Patients in the retreatment group received additional endoscopic heat probe therapy at 24 hours, the follow-up was otherwise similar. Forty men with major ulcer hemorrhage were randomized, 19 to the retreatment group and 21 to the no-retreatment group. Patients in the two groups had similar Baylor Bleeding Scores, blood transfusion needs (median three vs. two units), ulcer sites (duodenal 57{\%} vs. 43{\%}), stigmata of hemorrhage (actively bleeding 68{\%} vs. 67{\%}), and received similar initial endoscopic therapy (heat probe 240 J vs. 300 J). Patients in the retreatment group received additional heat probe therapy (median 165 J) at 24 hours. Results: Rebleeding, requiring significantly more blood transfusion, occurred in 24{\%} of the no-retreatment group patients compared to none of the retreatment group patients (p < 0.05). Conclusions: Endoscopic retreatment after successful initial endoscopic hemostasis prevents rebleeding in high-risk patients with ulcer bleeding.",
author = "Saeed, {Z. A.} and Cole, {R. A.} and Ramirez, {Francisco C} and Schneider, {F. E.} and Hepps, {K. S.} and Graham, {D. Y.}",
year = "1996",
month = "3",
language = "English (US)",
volume = "28",
pages = "288--294",
journal = "Endoscopy",
issn = "0013-726X",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding

T2 - A prospective randomized trial

AU - Saeed, Z. A.

AU - Cole, R. A.

AU - Ramirez, Francisco C

AU - Schneider, F. E.

AU - Hepps, K. S.

AU - Graham, D. Y.

PY - 1996/3

Y1 - 1996/3

N2 - Background and Study Aims: Rebleeding after initial endoscopic hemostasis remains an important determinant of poor prognosis in patients with ulcer hemorrhage. Prospective identification of patients who are at high risk for rebleeding, and directing further therapeutic measures in these patients, would be expected to improve the prognosis. Patients and Methods: We used our previously described scoring system (the Baylor Bleeding Score) to identify patients at increased risk for rebleeding after initially successful endoscopic hemostasis, and randomized them into retreatment and no-retreatment groups. Patients in the retreatment group received additional endoscopic heat probe therapy at 24 hours, the follow-up was otherwise similar. Forty men with major ulcer hemorrhage were randomized, 19 to the retreatment group and 21 to the no-retreatment group. Patients in the two groups had similar Baylor Bleeding Scores, blood transfusion needs (median three vs. two units), ulcer sites (duodenal 57% vs. 43%), stigmata of hemorrhage (actively bleeding 68% vs. 67%), and received similar initial endoscopic therapy (heat probe 240 J vs. 300 J). Patients in the retreatment group received additional heat probe therapy (median 165 J) at 24 hours. Results: Rebleeding, requiring significantly more blood transfusion, occurred in 24% of the no-retreatment group patients compared to none of the retreatment group patients (p < 0.05). Conclusions: Endoscopic retreatment after successful initial endoscopic hemostasis prevents rebleeding in high-risk patients with ulcer bleeding.

AB - Background and Study Aims: Rebleeding after initial endoscopic hemostasis remains an important determinant of poor prognosis in patients with ulcer hemorrhage. Prospective identification of patients who are at high risk for rebleeding, and directing further therapeutic measures in these patients, would be expected to improve the prognosis. Patients and Methods: We used our previously described scoring system (the Baylor Bleeding Score) to identify patients at increased risk for rebleeding after initially successful endoscopic hemostasis, and randomized them into retreatment and no-retreatment groups. Patients in the retreatment group received additional endoscopic heat probe therapy at 24 hours, the follow-up was otherwise similar. Forty men with major ulcer hemorrhage were randomized, 19 to the retreatment group and 21 to the no-retreatment group. Patients in the two groups had similar Baylor Bleeding Scores, blood transfusion needs (median three vs. two units), ulcer sites (duodenal 57% vs. 43%), stigmata of hemorrhage (actively bleeding 68% vs. 67%), and received similar initial endoscopic therapy (heat probe 240 J vs. 300 J). Patients in the retreatment group received additional heat probe therapy (median 165 J) at 24 hours. Results: Rebleeding, requiring significantly more blood transfusion, occurred in 24% of the no-retreatment group patients compared to none of the retreatment group patients (p < 0.05). Conclusions: Endoscopic retreatment after successful initial endoscopic hemostasis prevents rebleeding in high-risk patients with ulcer bleeding.

UR - http://www.scopus.com/inward/record.url?scp=0029892527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029892527&partnerID=8YFLogxK

M3 - Article

C2 - 8781792

AN - SCOPUS:0029892527

VL - 28

SP - 288

EP - 294

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - 3

ER -